##TransplantSky
LightNews LightNews
ishlt.bsky.social
Did you know #ISHLTMembers get the best rates to #ISHLT2026? 💸 Join now to save on the meeting of the year + enjoy all other member benefits. ➡️ Sign up today: 🔗 www.ishlt.org/membership

#TransplantSky
February 10, 2026 at 4:23 PM
jhlt.bsky.social
Learn about:
🫁 Assessing patients for STS
🔎 Which patients to screen
📈 How the diagnosis influences #transplant decision making, risk assessment
💊 Impacts to #immunosuppression
🩺 Extrapulmonary comorbidities
🔮 Future areas for research

#medsky #pulmsky #transplantsky

www.ishlt.org/about/news-d...
ISHLT Consensus Statement on STS and Lung Transplantation on the JHLT Podcast
Joined by the three document leads, JHLT the Podcast discusses the latest Consensus Statement from ISHLT, exploring short telomere syndrome (STS) and lung transplantation.
www.ishlt.org
February 4, 2026 at 2:29 PM
jhlt.bsky.social
Critically shortened #telomeres influence #InterstitialLungDisease.

Today on #JHLTThePodcast, we talk with the document leads of the latest #ISHLT Consensus Statement, Short Telomere Syndrome and #LungTransplantation.

www.ishlt.org/about/news-d...

#medsky #pulmsky #transplantsky
ISHLT Consensus Statement on STS and Lung Transplantation on the JHLT Podcast
Joined by the three document leads, JHLT the Podcast discusses the latest Consensus Statement from ISHLT, exploring short telomere syndrome (STS) and lung transplantation.
www.ishlt.org
February 4, 2026 at 2:29 PM
ishlt.bsky.social
Check out the latest #ISHLT Standards & Guidelines documents. 8️⃣ were published last year, engaging 169 experts from around the globe. 🌍 Learn more at 🔗 bit.ly/49NdOqt

#TransplantSky #MedSky
ISHLT Standards & Guidelines 2025 Year in Review
ISHLT develops Professional Guidelines and Consensus Documents regarding professional practice matters and the care of patients with advanced heart and/or lung disease. In 2025, ISHLT published eight ...
bit.ly
February 2, 2026 at 3:01 PM
ishlt.bsky.social
📌 Webinar de #ISHLTenEspañol: Consideraciones Médicas, Quirúrgicas, y Anestésicas en el Trasplante para Hipertensión Pulmonar Arterial
🗓️ 11 de Marzo
🔗 Ver el programa y regístrate ahora: https://bit.ly/4qNG4R2
##MedSky #TransplantSky #PAH
January 29, 2026 at 10:45 PM
ishlt.bsky.social
The January #ISHLTJournalWatch focuses on topics in #transplant #pharmacy, edited by Colleen Hutchinson. 💊

Topics include the NUDT16 genotype, #daratumumab monotherapy, & early mammalian target of rapamycin inhibitor (#mTORi).

🔗 www.ishlt.org/about/news-d...

#TransplantSky #PharmSky
Pharmacy in Heart and Lung Transplant: The Latest Studies in ISHLT Journal Watch
The first Journal Watch of 2026 explores topics in transplant pharmacy, including valganciclovir for CMV, daratumumab monotherapy, and renal sparing in heart transplant recipients.
www.ishlt.org
January 26, 2026 at 3:23 PM
ishlt.bsky.social
In 2025, #ISHLT published 8️⃣ documents regarding professional practice matters and the care of patients with advanced heart and/or lung disease. The Standards & Guidelines program engaged 169 total participants. 💡📚🌎

➡️ Check out the latest documents at 🔗 bit.ly/49NdOqt

#TransplantSky #MedSky
January 23, 2026 at 3:08 PM
ishlt.bsky.social
Join ISHLT's #PVD #InterdisciplinaryNetwork next week for a discussion on managing critically ill patients with #PVD. 🖥️💡

➡️ View the program + register: https://bit.ly/4pDzNXE
##MedSky #TransplantSky
January 22, 2026 at 8:42 PM
jhlt.bsky.social
On today's #JHLT podcast, Salma Karim and Hans Eiskjær of @au.dk Hospital join early career guest host Bin Yang of Mass General in Boston to discuss the impact of #evolocumab on coronary physiology and microstructure in heart transplant.

#cardiosky #transplantsky #medsky
Evolocumab's Impact on Coronary Physiology on JHLT: The Podcast
The JHLT team discusses a study from Aarhus University Hospital in Denmark on the impact evolocumab may have on coronary physiology and microstructure in de-novo heart transplant recipients.
www.ishlt.org
January 21, 2026 at 2:54 PM
ishlt.bsky.social
🚨 #CallforPapers: Submit your papers on Primary Graft Dysfunction (PGD) in thoracic organ #transplantation to @jhlt.bsky.social. 🫀🫁 Submissions will be accepted until 📆 28 February: 🔗 bit.ly/4r6vuog

#PGD #JHLT #TransplantSky #MedSky
January 20, 2026 at 2:55 PM
ishlt.bsky.social
Hear about game-changing #ISHLT moments from ISHLT leaders and community members. 🫀🫁🎯

#TransplantSky #MedSky
January 16, 2026 at 3:41 PM
ishlt.bsky.social
📢 It's the FINAL WEEK to submit applications to 4️⃣ #ISHLTResearchGrants.⠀⠀
⏰ Submit by 20 January at 11:59 p.m. ET / 21 January at 03:59 UTC⠀⠀
📖 Learn more and apply at 🔗 https://bit.ly/4p6WX8f
##ECPImmunmodulation #PedsTx #HeartTx #LungTx #research #MedSky #TransplantSky
January 12, 2026 at 4:25 PM
ishlt.bsky.social
Continuing #pulmsky studies in December's #ISHLTJournalWatch, Muhammad Hayat-Syed of @bcmhouston.bsky.social highlights a study on the distinctions between short- and long-term outcomes for #lungtxp patients with connective tissue disease.

#transplantsky #surgerysky
The third slide of December 2025's ISHLT Journal Watch, reviewing the study "Outcomes of Lung Transplantation for end stage lung disease with connective tissue disease: a systematic review and meta-analysis." A more screenreader friendly version of the issue can be found at https://www.ishlt.org/docs/default-source/journal-watch/202512_journalwatch_pulm_dec2025.pdf
January 7, 2026 at 9:28 PM
jhlt.bsky.social
Happy new year from JHLT! Our Digital Media Editors kick off the new season of the podcast with a year-end recap, each sharing one of their favorite studies from 2025.

#cardiosky #pulmsky #medsky #transplantsky

www.ishlt.org/about/news-d...
JHLT: The Podcast Looks Back on the Best Studies of 2025
Happy new year from JHLT: The Podcast! The Digital Media Editors kick off the new season with a year-end recap, each sharing one of their favorite studies from the JHLT published in 2025.
www.ishlt.org
January 7, 2026 at 4:05 PM
ishlt.bsky.social
Finally, on Friday, 16 January, the #pulmonology community will explore lung transplant in patients with interstitial lung disease associated connective tissue disease ( #CTD-ILD).

www.ishlt.org/event-calend...

#pulmsky #medsky #transplantsky
Navigating the Complexities of Lung Transplantation in Connective Tissue Disease–Associated ILD
This webinar will explore the evolving landscape of CTD-ILD transplantation, highlighting advances in patient selection, surgical considerations, and post-transplant management.
www.ishlt.org
January 5, 2026 at 5:45 PM
ishlt.bsky.social
On 13 January, the Advanced Heart Failure and Transplantation Interdisciplinary Network provides a comprehensive overview of normothermic regional perfusion ( #NRP) in #DCD heart transplant.

www.ishlt.org/event-calend...

#cardiosky #medsky #transplantsky
NRP at the Heart of DCD: Challenges and Opportunities
This webinar provides a comprehensive overview of emerging practices, outcomes, and ethical considerations surrounding the use of normothermic regional perfusion (NRP) in donation after circulatory de...
www.ishlt.org
January 5, 2026 at 5:45 PM
ishlt.bsky.social
There's four #ISHLT webinars next week on #ISHLTv. Let's round them up for #medsky and #transplantsky.

First, on 12 January, the Research and #Immunology Professional Community explores the diagnosis of #AMR in #LungTransplant recipients.

www.ishlt.org/event-calend...
Multi-Disciplinary Approach for Diagnosis of Antibody Mediated Rejection (AMR) in Lung Transplant Recipients – A Guide
A case presentation of antibody mediated rejection (AMR) in a lung transplant recipient, in which the multi-disciplinary approach is illustrated by the contribution of each expert, highlighting the sp...
www.ishlt.org
January 5, 2026 at 5:45 PM
ishlt.bsky.social
LAST CALL: Submit your papers on device therapies for advanced #HeartDisease & #LungDisease to @TheJHLT by Tuesday, 30 December. 🫀🫁 🔗: https://bit.ly/48RJQBk
##CallforPapers #HeartTx #LungTx #MedSky #TransplantSky
December 27, 2025 at 10:06 PM
ishlt.bsky.social
The December #ISHLTJournalWatch highlights pulmonology research, edited by @sirusjj.bsky.social.

Topics include gliptins and #CLAD, #cfDNA in #EVLP perfusate, lung allocation strategy, and #connectivetissue diseases in #lungtx.

#ISHLT #pulmsky #transplantsky

www.ishlt.org/about/news-d...
ISHLT Early Career-Led Literature Review in Pulmonology
The December 2025 issue of ISHLT's Journal Watch explores topics in pulmonology, advanced lung failure, and transplant.
www.ishlt.org
December 22, 2025 at 2:40 PM
jhlt.bsky.social
Can antiphospholipid antibody titers predict #postop outcomes for #CTEPH patients after #PEA? We discuss with Camille Miard and François Stéphan of Hôpital Marie Lannelongue on #JHLTThePodcast this month.

#MedSky #TransplantSky #PulmSky

www.ishlt.org/about/news-d...
JHLT Podcast: Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy
The JHLT Digital Media Editors host a discussion with Camille Miard and François Stéphan of the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.
www.ishlt.org
December 17, 2025 at 3:00 PM
ishlt.bsky.social
📢 A NEW #ISHLT Consensus Statement on the considerations for endpoints in #LungTransplantation clinical trials is now available. 📖💡🫁 Check out the top takeaways ⏬ and read the publication at the 🔗 bit.ly/3KKboR7

#TransplantSky #MedSky
December 16, 2025 at 2:47 PM
ishlt.bsky.social
Closing out November's #ISHLTJournalWatch, @sarawinndong.febrilepodcast.com reviews a study from @jhlt.bsky.social on the use of #Maribavir for #CMV infection in SOT recipients—an important addition to the toolbox in treating this infection in #transplant recipients.

#TransplantSky #IDSky #MedSky
The third slide from the November 2025 issue of Journal Watch, titled "Maribavir for refractory cytomegalovirus (CMV) infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study" For a more screenreader friendly version, the full issue PDF is at https://www.ishlt.org/docs/default-source/journal-watch/202511_journalwatch_id_nov2025.pdf.
December 15, 2025 at 5:37 PM
ishlt.bsky.social
📢 Registration for #ISHLT2026 is NOW OPEN! Join your global, multidisciplinary colleagues in Toronto.
✨ New this year: you can book your hotel at exclusive room rates while registering. ➡️ Register by 4 February 📅 to qualify for the early registration fee: 🔗 bit.ly/4aFzxTd

#TransplantSky #MedSky
December 10, 2025 at 6:31 PM
ishlt.bsky.social
Discover the latest in #LungTransplantation at the #ISHLT + @sts.org joint symposium next month at #STS2026. 🫁

📆 29 January | New Orleans, LA USA
✅ CME credits available
🎟️ One-day passes available for those who want to attend the symposium only!

➡️ Register at 🔗 bit.ly/4aonIkz

#TransplantSky
December 9, 2025 at 4:01 PM
ishlt.bsky.social
On #ISHLTJournalWatch this month, Brennan Collis reviews a paper from @jhlt.bsky.social on the clinical efficacy and tolerability of #letermovir for #CMV prophylaxis after #HeartTx.

#CardioSky #TransplantSky #IDsky #MedSky
The second slide from the November 2025 issue of Journal Watch, titled "Tolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation" For a more screenreader friendly version, the full issue PDF is at https://www.ishlt.org/docs/default-source/journal-watch/202511_journalwatch_id_nov2025.pdf.
December 8, 2025 at 9:10 PM